首页> 外国专利> 6,7,8,9 - tetrahydro - 5H - benzocicloheptenil aciladas amines, method for their Synthesis, Pharmaceutical compositions and the use of said compounds for the manufacture of medicinal products

6,7,8,9 - tetrahydro - 5H - benzocicloheptenil aciladas amines, method for their Synthesis, Pharmaceutical compositions and the use of said compounds for the manufacture of medicinal products

机译:6,7,8,9-四氢-5H-苯并环庚烯基阿西达斯胺,其合成方法,药物组合物和所述化合物在生产医药产品中的用途

摘要

6.7, 8, 9-tetrahydro-5h-benzocyclohepenil-amine acilada, characterized by any proportion of the total formula (1) of any form of stereoisomer or a mixture thereof or one of the salts acceptable on its drugs, wherein: R1 and R4 are independently selected from the following h groups: C1-10, alquenilo C2-10 and C2-10 are unreplaced and at least single substituted C1-10 tars, and their substitutes are selected from the unreplaced group consisting of F, oh, Alcoy c1-8 mercato, CN, coor6, conr7r8, phenyl and isobutylene, and from at least one single substitution group, the substitutes are selected from the halogen and pseudo halogen groups,C1-3, alcox c1-3 and CF3, non substituted phenanthrene and non substitute, and at least one single substitute, selected from halogen, pseudo halogen, c1-3, alcox c1-3 and CF3, r9co, conr10r11, cour2, CF3, halogen, pseudo halogen, nr13r14, or15, s (o) MR16, so2n17r18 and NO2, R2 and R3, Independently, alternatives are selected from a group consisting of H, halogen, pseudo halogen, C1-10 asphalt, unsubstituted C1-10 asphalt, and at least one single alternative, including Oh, phenyl and isopropene, oh, alcox C1-10, phenyl, s (o) mr19, CF3, CN, NO2, C1-10 amine tar, -C1-10- amineC1-6-Conh--The unreplaced phenyl-conh and phenyl-so2-o are at least a single substitute, which is selected from the hydrocarbon groups of halogen, pseudo halogen, CH3 and metoxi, C1-6 so2-o -,1. C1-6 co type is not an alternative and at least a single alternative tar. Its alternatives are selected from group F, di codil c1-3 amino, pirrolidini and piperidinilo, and phenyl Co. its phenyl part can be replaced by one or more alternatives consisting of c1-3, halogen and thyroid; A selected from CH2, CHH and CH asphalt c1-3 groups; B selected from CH2 and ch1-3 groups; C independently, it has the same meaning as B; D independently, it has the same meaning as B; R5 is ar group or hetar group,both of which may be unsubstituted or carry one or more substituents selected from the group consisting of halogens, pseudohalogens, NH2, C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, C1-10 alkoxy, C1-10 alkyl and unsubstituted and at least mono-substituted di-C 1-10 alkyl, whose substituents are selected from the group consisting of F, OH, C 1-8 alkoxy, aryloxy, C 1-8 mercapto alkyl, NH 2, C 1-8 amino alkyl and di- C1-8alkyl amino, C3-5 alkanediyl, phenyl, heteroaryl, C1-4alkyl substituted with aryl or heteroaryl, CF3, NO2, OH, phenoxy, benzyl-oxy, C1-10 alkyl COO, S (O) mR20, SH , phenylamino, benzylamino, C1-10 alkyl-CONH-,C1-10-has-c1-4, phenyl CONHPhenyl - containing - C1-4, heteromorphic - CONH,1. Pagan-c1-4, c1-10-co, c1-10-co, phenyl Co, pagan-co, cf3-co, och2o -,WaterOctabromodiphenyl ether-CH2CH2O...COOR21 CONR22R23 CNH (NCH2)SO2NR24R25, R26SO2NH-,R27so2n-c1-6, and different cycles of 5 to 7 mononuclear, liquefied, saturated or at least single unsaturated members, including 1 to 3 heterocyclic atoms selected from the N, O and s groups, which can be replaced by one or more substitutes selected from the halogen, c1-3 and alcox c1-3 groups, Oxo and CF3, where these heterocycles can selectively condense with this ar or hetar group, where all arilo, heterosexual, phenyl, arilo groups containing isomerization and phenyl are selectively present in alternatives to this ar or hetar group,they may be substituted with one or more substituents selected from the group consisting of halogens, pseudohalogens, C1-3 alkyl, OH, C1-3 alkoxy and CF3; R6 is selected from the group consisting of: H, C1-10 alkyl which may be substituted with one or more substituents selected from the group consisting of F, C1-8 alkoxy and di- C1-8 amino alkyl, aryl-C1-4 alkyl and heteroaryl-C1-4alkyl, which may be substituted with one or more substituents selected from the group consisting of halogens, C1-4alkoxy and di- C1-6alkyl amino; R7 is selected from the group consisting of: H, C1-10 alkyl which may be substituted with one or more substituents selected from the group consisting of F, C1-8 alkoxy,1. Di-c1-8 amine and fenilo, fenilo, indan Nile and heaterilo, each of which may not be replaced or carry one or more group substitutes consisting of halogen, pseudo halogen, c1-3 tar, alcoxi c1-3 and CF3; R8 is h or C1-10 tar; R9 is selected from the group consisting of the following: C1-10 may not be replaced or carry one or more substitutes, including F, alcoxi C1-4, di coil c1-3 amino, non substituted phenyl and isopropene, and at least one single substitute selected from the group of c1-3, alcoxi c1-3, halogen, pseudohalogen and CF3; R10, independent,R11 has the same meaning as R7; R11 has the same meaning as R8 independently; R12 has the same meaning as R6 independently; R13 is selected from the following components: H, C1-6 tar, phenyl, benzene, isopropene, c1-6-co tar, phenyl CO and isopropene Co, selected substitutes R14 has the same meaning as R13 in the group consisting of halogen, pseudo halogen, c1-3 tar, alcoxi c1-3 and CF3 and may have one or more substitutes; R15 is selected from the group consisting of H, C1-10 tar, alcox c1-3-c1-3 tar and bencilo,1. The substituted and non substituted phenyl and isopropene are selected from halogen, pseudo halogen, c1-3 tar, alcoxi c1-3 and CF3, and one or more of them can be found; R16 is selected from the following groups: C1-10 tar, which can be replaced by one or more substitutes of F, OH, alcox C1-8, Ariloxi, C1-8 Mercato, C1-8 tar, C1-8 Amino and Di-Acquil C1-8 Amino, CF3, phenyl and substitutes and non substitutes selected from the composition group. 2. Halogen, pseudo halogen, c1-3 tar, Alcoy c1-3 and CF3,and where one or more of these substituents may be present; R17, independently, has the same meaning as R7; R18, independently, has the same meaning as R8; R19 independently, has the same meaning as R16; R20, independently, has the same meaning as R16; R21, independently, has the same meaning as R6; R22, independently, has the same meaning as R7; R23, independently, has the same meaning as R8; R24, independently, has the same meaning as R7; R25, independently, has the same meaning as R8; R26, independently, has the same meaning as R16; R17, independently,It has the same meaning as R16; heteromorphism is a single or double cycle heteromorphism with 5 to 10 members, containing one or more heteroatoms selected from n, O and s groups; hetar group is a single or double cycle heteromorphism with 5 to 10 aromatic members, It contains one or more heteroatoms selected from n, O and s groups; arilo is phenyl, naft-1-ilo or naft-2-ilo; AR group is phenyl, naft-1-ilo or naft-2-ilo; m is 0, 1 or 2; its synthesis method, 1. Drug synthesis and use of these compounds to manufacture drugs for cardiovascular disease, stable and unstable thoracic vascular disease;Coronary artery disease, congenital vascular disease, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis, peripheral artery occlusion, endocrine disorder, arteriosclerosis, myocardial infarction, hypertension, essential hypertension Pulmonary hypertension, secondary hypertension, regenerative hypertension, chronic colonic ulcer, erectile dysfunction, ventricular spasm, diabetes, diabetic complications, nephropathy, retinopathy, vascular disease, bronchial asthma, chronic renal failure, cirrhosis, osteoporosis,O reduced cardiovascular risk in women with limited memory or learning ability, or menopause or contraceptive use.
机译:6.7、8、9-四氢-5h-苯并环庚腈-胺阿西达达,其特征在于任何形式的立体异构体或其混合物的任何通式(1)或其混合物或其药物可接受的盐之一,其中:R1和R4选自以下h组:C1-10,alquenilo C2-10和C2-10是未取代的,至少有一个取代的C1-10焦油,其替代物选自F,OH,Alcoy c1 -8巯基,CN,coor6,conr7r8,苯基和异丁烯,并且选自至少一个单一取代基,所述取代基选自卤素和假卤素基团,C1-3,alcox c1-3和CF3,未取代的菲和非取代基和至少一个单一取代基,选自卤素,假卤素,c1-3,alcox c1-3和CF3,r9co,conr10r11,cour2,CF3,卤素,假卤素,nr13r14或15,s(o)MR16 ,so2n17r18和NO2,R2和R3独立地从H组成的组中选择卤素,假卤素,C1-10沥青,未取代的C1-10沥青和至少一个单独的替代物,包括Oh,苯基和异丙烯,oh,alcox C1-10,苯基,s(o)mr19,CF3,CN,NO2 ,C1-10胺焦油,-C1-10-胺C1-6-Conh-未取代的苯基-conh和苯基-so2-o是至少一个取代基,选自卤素,假卤素, CH3和甲氧,C1-6 so2-o-,1。 C1-6 co类型不是替代品,至少是一个替代焦油。它的替代物选自F,二环烷基c1-3氨基,吡咯烷基和哌啶子基和苯基Co。其苯基部分可用一种或多种由c1-3,卤素和甲状腺组成的替代物取代;选自CH2,CHH和CH沥青的c1-3组; B选自CH2和ch1-3组; C独立地具有与B相同的含义; D独立,与B具有相同的含义; R 5是芳基或杂芳基,它们均可未被取代或带有一个或多个选自卤素,假卤素,NH 2,C 1-10烷基,C 2-10烯基,C 2-10炔基,C 1-10的取代基烷氧基,C 1-10烷基和未取代的且至少是单取代的二C 1-10烷基,其取代基选自F,OH,C 1-8烷氧基,芳氧基,C 1-8巯基烷基, NH 2,C 1-8氨基烷基和二C1-8烷基氨基,C3-5烷二基,苯基,杂芳基,被芳基或杂芳基取代的C1-4烷基,CF3,NO2,OH,苯氧基,苄氧基,C1-10烷基COO,S(O)mR20,SH,苯基氨基,苄基氨基,C1-10烷基-CONH-,C1-10-has-c1-4,苯基CONHPhenyl-含-C1-4,杂晶-CONH,1。 Pagan-c1-4,c1-10-co,c1-10-co,苯基Co,pagan-co,cf3-co,och2o-,水邻溴二苯醚-CH2CH2O ... COOR21 CONR22R23 CNH(NCH2)SO2NR24R25,R26SO2NH-, R27so2n-c1-6,以及5至7个单核,液化,饱和或至少一个不饱和成员的不同环,包括1-3个选自N,O和s的杂环原子,可以被一个或多个取代基取代选自卤素,c1-3和alcox c1-3基团,Oxo和CF3,其中这些杂环可与该ar或hetar基团选择性缩合,其中所有芳基,异性基,苯基,含异构化基团和苯基的芳基均存在于该ar或hetar基团的替代物,它们可以被一个或多个选自卤素,假卤素,C1-3烷基,OH,C1-3烷氧基和CF3的取代基取代; R 6选自:H,可被一个或多个选自F,C 1-8烷氧基和二-C 1-8氨基烷基,芳基-C 1-4的取代基取代的C 1-10烷基。烷基和杂芳基-C 1-4烷基,它们可以被一个或多个选自卤素,C 1-4烷氧基和二-C 1-6烷基氨基的取代基取代; R 7选自:H,C 1-10烷基,其可以被一个或多个选自F,C 1-8烷氧基,1的取代基取代。 Di-c1-8胺和fenilo,fenilo,indan Nile和Heatilo,它们中的每一个都不能被取代或带有一个或多个由卤素,假卤素,c1-3焦油,醇c1-3和CF3组成的组取代基; R8是h或C1-10焦油; R9选自下列各项:C1-10不能被取代或带有一个或多个取代基,包括F,醇C1-4,二线圈c1-3氨基,未取代的苯基和异丙基,以及至少一个选自c1-3,alcoxi c1-3,卤素,假卤素和CF3的单一取代基; R10,独立,R11与R7含义相同; R11分别与R8具有相同的含义; R12独立地与R6具有相同的含义; R13选自下列成分:H,C1-6焦油,苯基,苯,异丙基,c1-6-焦油,苯基CO和异丙烯Co,在由卤素组成的组中,选择的取代基R14的含义与R13相同,假卤素,c1-3焦油,alcoxi c1-3和CF3,可能有一个或多个替代物; R 15选自H,C1-10焦油,alcox c1-3-c1-3焦油和bencilo,1。取代的和未取代的苯基和异丙基选自卤素,伪卤素,c1-3焦油,醇c1-3和CF3,可以找到它们中的一个或多个。 R16选自以下组:C1-10焦油,可被F,OH,alcox C1-8,Ariloxi,C1-8 Mercato,C1-8焦油,C1-8氨基和Di的一种或多种替代物取代-Acquil C1-8氨基,CF3,苯基以及选自组成组的取代基和非取代基。 2.卤素,假卤素,c1-3焦油,醇c1-3和CF3,以及其中可能有一个或多个取代基的化合物; R17独立地具有与R7相同的含义; R18独立地具有与R8相同的含义; R19独立,与R16含义相同; R20独立地具有与R16相同的含义; R21独立地具有与R6相同的含义; R22独立地具有与R7相同的含义; R23独立地具有与R8相同的含义; R24独立地具有与R7相同的含义; R25独立地具有与R8相同的含义; R26独立地具有与R16相同的含义; R17,独立,与R16含义相同;异质性是具有5至10个成员的单环或双环异质性,包含一个或多个选自n,O和s组的杂原子;杂芳基是具有5-10个芳族成员的单环或双环异质性,它含有一个或多个选自n,O和s基团的杂原子;芳基是苯基,萘基-1-ilo或萘基-2-ilo; AR基团是苯基,萘基-1-ilo或萘基-2-ilo; m为0、1或2;其合成方法:1.药物合成及使用这些化合物制造用于心血管疾病,稳定和不稳定的胸腔血管疾病的药物;冠状动脉疾病,先天性血管疾病,急性冠脉综合征,心力衰竭,心肌梗塞,中风,血栓形成,外周血动脉阻塞,内分泌失调,动脉硬化,心肌梗塞,高血压,原发性高血压肺动脉高压,继发性高血压,再生性高血压,慢性结肠溃疡,勃起功能障碍,心室痉挛,糖尿病,糖尿病并发症,肾病,视网膜病,血管疾病,支气管哮喘,慢性肾功能衰竭,肝硬化,骨质疏松症,O降低记忆力或学习能力有限,更年期或避孕药具妇女的心血管风险。

著录项

  • 公开/公告号AR035431A1

    专利类型

  • 公开/公告日2004-05-26

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMA DEUTSCHLAND GMBH;

    申请/专利号AR2002P100441

  • 发明设计人

    申请日2002-02-11

  • 分类号C07C233/65;C07C233/64;C07C233/74;C07C235/54;C07D213/56;C07D307/78;C07D317/60;C07D333/24;A61K31/166;A61P9/00;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号